ABSTRACT ID NO: IRIA - 1085 - PowerPoint PPT Presentation

1 / 25
About This Presentation
Title:

ABSTRACT ID NO: IRIA - 1085

Description:

Title: Slide 1 Author: Radiology Last modified by: Radiology Created Date: 8/16/2006 12:00:00 AM Document presentation format: On-screen Show (4:3) Other titles – PowerPoint PPT presentation

Number of Views:102
Avg rating:3.0/5.0
Slides: 26
Provided by: Radi50
Category:
Tags: abstract | iria | takeshi

less

Transcript and Presenter's Notes

Title: ABSTRACT ID NO: IRIA - 1085


1
ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND
CERVICAL LESIONS
  • ABSTRACT ID NO IRIA - 1085

2
INTRODUCTION
  • Increasingly used in abdomen and pelvis since the
    last decade
  • DWI ? ADC(Apparent Diffusion Coefficient) ?
    Cellularity
  • Increased Cellularity ? Impeded diffusion

3
REVIEW OF LITERATURE
Role of diffusion weighted imaging in the
diagnosis of gynecological diseases Tomohiro
Namimoto,Kazuo Awai,Takeshi Nakaura,Yumi Yanaga
European Society of Radiology 2008
4
REVIEW OF LITERATURE
  • Important cancer biomarker
  • Aids in superior lesion characterization, tumor
    staging, treatment planning, and disease
    follow-up of gynaecological tumors
  • Help predict and assess treatment response
    earlier than other techniques
  • Can detect residual / recurrent tumor

Diffusion-weighted Imaging of Gynecologic Tumors
Diagnostic Pearls and Potential Pitfalls Sunita
Dhanda, et al Radiographics 2014 3413931416
5
AIM
  • To assess role of Diffusion weighted imaging
    (DWI) in differentiating benign from malignant
    lesions of uterus and cervix

6
MATERIALS AND METHODS
  • 24 patients with uterine and cervical lesions
  • 15 control patients with normal uterus and cervix
  • DWI  with b value 800 as a part of routine MR
    imaging on 1.5T MRI
  • Apparent diffusion coefficient (ADC) calculated
    and correlated with histopathology
  • Inclusion criteria Patients with lesions of
    uterus and cervix who have undergone MRI and who
    have HPE follow up
  • Exclusion criteria Patients who have
    contraindications to MR imaging and who have no
    HPE follow up

7
PROFORMA
  • Name
  • Age
  • Hospital No
  • Date Of MRI Study
  • Clinical History
  • Previous USG,CT,MRI findings
  • Findings at MRI with special emphasis on DWI
  • Clinical Follow Up
  • HPE Diagnosis

8
PATHOLOGIES
(n2)
(n5)
(n12)
(n5)
9
CARCINOMA ENDOMETRIUM
F/65, Post menopausal bleeding
T2 WI
ADC 0.648x10-3mm2/s
ADC
DWI
10
CARCINOMA ENDOMETRIUM
F/52, Menorrhagia
T2 WI
ADC 0.712 x10-3mm2/s
DWI
ADC
11
ADC Normal Endometrium
ADC Ca Endometrium
S.NO. CONTROL ADC VALUES (X 10-3mm2/s)
1. 1.42
2. 1.29
3. 1.33
4. 1.43
5. 1.59
6. 1.45
7. 1.34
8. 1.46
9. 1.42
10. 1.42
11. 1.47
12. 1.59
13. 1.42
14. 1.49
15. 1.41
S.No ADC VALUES (X 10-3mm2/s)
1. 1.29
2. 0.712
3. 0.619
4. 0.94
5. 0.981
Range 1.29 to 1.59 x 10-3mm2/s Mean ADC 1.44 x
10-3 mm2/s
Range 0.619 to 1.29 x 10-3mm2/s Mean ADC
0.88 x 10-3mm2/s
12
NPAR TESTSMANN-WHITNEY TEST
RANKS
TEST STATISTICS
ANN ANN N Mean Rank Sum of Ranks
Endometrium ABNORMAL 5 3.10 15.50
Endometrium NORMAL 15 12.97 194.50
Endometrium Total 20    
  Endometrium
Mann-Whitney U .500
Wilcoxon W 15.500
Z -3.244
Asymp. Sig. (2-tailed) .001
Exact Sig. 2(1-tailed Sig.) .000b
a. Grouping Variable ANN
b. Not corrected for ties
13
CARCINOMA CERVIX
F/57Post menopausal bleeding
T2 WI
ADC 0.923x10-3mm2/s
DWI
ADC
14
CARCINOMA CERVIX
F/57 ,White discharge
T2 WI
ADC 0.977 x 103mm2/s
DWI
ADC
15
ADC values of normal cervix
ADC values of Carcinoma cervix
S.No CONTROL ADC VALUES X 10-3mm2/S
1 1.35
2 1.37
3 1.40
4 1.56
5 1.42
6 1.46
7 1.37
8 1.36
9 1.34
10 1.36
11 1.43
12 1.37
13 1.36
14 1.32
15 1.37
S.No ADC VALUES X 10-3mm2/S
1 0.618
2 1.104
3 0.886
4 1.012
5 0.977
Range 1.32 to 1.56 x10-3mm2/s Mean ADC 1.39
x10-3mm2/s
Range 0.618 to 1.012 x10-3mm2/s Mean ADC 0.909
x10-3mm2/s
16
NPAR TESTSMANN-WHITNEY TEST
TEST STATISTICS
RANKS
ANN ANN N Mean Rank Sum of Ranks
CERVIX ABNORMAL 5 3.0 15.00
CERVIX NORMAL 15 13.0 195.00
CERVIX Total 20    
  CERVIX
Mann-Whitney U 0.000
Wilcoxon W 15.000
Z -3.291
Asymp. Sig. (2-tailed) .001
Exact Sig. 2(1-tailed Sig.) .000b
a. Grouping Variable ANN
b. Not corrected for ties.
17
LEIOMYOMA
F/43,Menorrhagia,dysmenorrhoea
T2 WI
ADC 1.616 x10-3mm2/s
ADC
DWI
18
LEIOMYOMAS
F/43 Menorrhagia
T2 WI
ADC 1.256 x10-3mm2/s
ADC
DWI
19
ADC values of normal myometrium
ADC values of Leiomyoma
S.NO CONTROL ADC VALUES X 10-3mm2/s
1. 1.57
2. 1.39
3. 1.64
4. 1.68
5. 1.51
6. 1.54
7. 1.46
8. 1.54
9. 1.56
10. 1.52
11. 1.42
12. 1.54
13. 1.54
14. 1.53
15. 1.52
S.NO. ADC VALUES X 10-3mm2/s
1 2.27
2 1.77
3 1.59
4 1.53
5 1.54
6 1.206
7 1.828
8 2.059
9 1.616
10 1.256
11 2.1
12 1.41
Range 1.39 to 1.68 x10-3mm2/s Mean ADC 1.53
x10-3mm2/s
Range 1.24 to 2.27 x10-3mm2/s Mean ADC
1.67x10-3mm2/s
20
STATISTICAL ANALYSIS T-TEST
Group Statistics Group Statistics Group Statistics Group Statistics Group Statistics Group Statistics
MF MF N Mean Std. Deviation Std. Error Mean
VALUES MYOMETRIUM 15 1.5313 .07308 .01887
VALUES FIBROID 12 1.6799 .33624 .09706
21
STATISTICAL ANALYSIS (Cont)
Independent Samples Test Independent Samples Test Independent Samples Test Independent Samples Test Independent Samples Test Independent Samples Test Independent Samples Test Independent Samples Test Independent Samples Test Independent Samples Test Independent Samples Test
    Levene's Test for Equality of Variances Levene's Test for Equality of Variances t-test for Equality of Means t-test for Equality of Means t-test for Equality of Means t-test for Equality of Means t-test for Equality of Means t-test for Equality of Means t-test for Equality of Means
    F Sig. t df Sig. (2-tailed) Mean Difference Std. Error Difference 95 Confidence Interval of the Difference 95 Confidence Interval of the Difference
    F Sig. t df Sig. (2-tailed) Mean Difference Std. Error Difference Lower Upper
VALUES Equal variances assumed 20.595 .000 -1.671 25 .107 -.14858 .08894 -.33176 .03459
VALUES Equal variances not assumed     -1.503 11.834 .159 -.14858 .09888 -.36436 .06720
22
ADENOMYOSIS
F/40 Dysmenorrhea,
T2 WI
ADC 1.506 x10-3mm2/s
DWI
ADC
ADC values of adenomyosis 1.458 x 10-3mm/s and
1.506 x 10-3mm/s
23
RESULTS
  • Significant reduction in ADC values of malignant
    lesions as compared to benign ones
  • Mean ADC of Ca Endometrium (0.88 x10-3mm2/s ) lt
    Mean ADC of normal Endometrium (1.44 x10-3mm2/s )
  • Mean ADC of Ca Cervix (0.9 x10-3mm2/s) lt Mean ADC
    of normal Cervix (1.39 x10-3mm2/s )

24
CONCLUSION
  • DWI with quantification of ADC values plays a
    major role in distinguishing benign and malignant
    lesions
  • DWI should be part of routine MR protocol when
    imaging the uterus and cervix

25
  • THANK YOU..
Write a Comment
User Comments (0)
About PowerShow.com